Growth Metrics

Whitehawk Therapeutics (WHWK) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - -101.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -101.40%
Dec 31, 2025 80.56%
Sep 30, 2025 -909.29%
Jun 30, 2025 -553.69%
Mar 31, 2025 2,283.08%
Dec 31, 2024 68.44%
Sep 30, 2024 -1,753.98%
Jun 30, 2024 -137.05%
Mar 31, 2024 -83.15%
Dec 31, 2023 93.83%
Sep 30, 2023 -96.01%
Jun 30, 2023 408.80%
Mar 31, 2023 74.02%
Dec 31, 2022 -673.42%
Sep 30, 2022 -89.26%
Jun 30, 2022 -239.28%
Mar 31, 2022 -280.00%
Dec 31, 2021 -278.20%
Sep 30, 2021 1,048.38%
Jun 30, 2021 -131.64%
Mar 31, 2021 369.89%
Dec 31, 2020 32.68%
Sep 30, 2020 -231.10%
Jun 30, 2020 295.46%
Mar 31, 2020 57.14%
Dec 31, 2019 21.45%
Sep 30, 2019 -19,917.13%
Jun 30, 2019 -109.57%
Mar 31, 2019 -41.40%
Dec 31, 2018 -35.67%
Sep 30, 2018 100.60%
Jun 30, 2018 974.55%
Mar 31, 2018 -119.39%
Dec 31, 2017 -1,614.81%
Sep 30, 2017 -1,265.13%
Jun 30, 2017 -58.27%
Mar 31, 2017 941.69%
Dec 31, 2016 2,358.15%
Sep 30, 2016 -7,596.89%
Jun 30, 2016 -30,032.41%
Mar 31, 2016 -22,201.51%
Dec 31, 2015 197.26%
Sep 30, 2015 -124.87%
Jun 30, 2015 -903.19%
Mar 31, 2015 4,606.00%
Dec 31, 2014 -214.16%
Sep 30, 2014 79.06%
Jun 30, 2014 -108.37%
Mar 31, 2014 78.96%
Dec 31, 2013 -411.73%
Sep 30, 2013 -107.27%
Jun 30, 2013 209.99%
Mar 31, 2013 -109.76%
Dec 31, 2012 60.90%
Sep 30, 2012 -26.45%
Jun 30, 2012 7.25%
Mar 31, 2012 960.11%
Dec 31, 2011 -108.14%
Sep 30, 2011 11.58%